EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

I53-50: Engineered icosahedral protein cage for modular vaccine nanoplatform

Ke Liang, Shuang Wu, Sihang Dong, Tao Xu, Hongtao Wang

Journal of Microbiology · 31.05.2026 · 64 (5) · e2511020

DOI: 10.71150/jm.2511020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Microbiology, erschienen am 31.05.2026. Verfasst von Ke Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Immunology in Chronic Diseases, Laboratory Medicine Experimental Center, Laboratory Medicine College, Bengbu Medical…. Hauptthemen laut MEDLINE: Nanovaccines, Protein Engineering, Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of the Anhui Higher Education Institutions, Bengbu City science and technology project, Key Projects of Natural Science Foundation of Bengbu Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

I53-50 is a computationally designed, self-assembling protein nanoparticle (NP) that forms a stable icosahedral structure composed of 120 protein subunits coordinated through precise interfacial interactions. Through unique intelligent regulation, I53-50 exhibits sensitivity to environmental signals and display multimodal “nano-smart” properties. I53-50 has a variety of modifiable surface-active sites, which facilitates precise chemical modification, gene fusion, tag coupling, and other functionalizations, thereby promoting effective lymphatic uptake and optimizing the immune response. I53-50 NPs show great potential in vaccine development, drug delivery, and biomaterials, representing a model fusion of computational biology and nanomedicine and offering a versatile tool for precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanovaccinesProtein EngineeringVaccinesAnimalsHumansDrug Delivery SystemsNanomedicineNanoparticlesVaccine Development

Stichwörter der Autor:innen

I53-50gene fusionnanoparticlesself-assemblyvaccine

Substanzen

NanovaccinesVaccines

Autor:innen und Institutionen

  • Anhui Province Key Laboratory of Immunology in Chronic Diseases, Laboratory Medicine Experimental Center, Laboratory Medicine College, Bengbu Medical University, Bengbu 233030, P. R. China.

Förderung

  • Natural Science Foundation of the Anhui Higher Education Institutions
  • Bengbu City science and technology project
  • Key Projects of Natural Science Foundation of Bengbu Medical University

Zitieren

APA

Liang, K., Wu, S., Dong, S., Xu, T., & Wang, H. (2026). I53-50: Engineered icosahedral protein cage for modular vaccine nanoplatform. Journal of Microbiology, 64(5), e2511020. https://doi.org/10.71150/jm.2511020

Vancouver

Liang K, Wu S, Dong S, Xu T, Wang H. I53-50: Engineered icosahedral protein cage for modular vaccine nanoplatform. Journal of Microbiology. 2026;64(5):e2511020. doi:10.71150/jm.2511020

BibTeX
@article{Liang2026,
  author = {Liang, Ke and Wu, Shuang and Dong, Sihang and Xu, Tao and Wang, Hongtao},
  title = {I53-50: Engineered icosahedral protein cage for modular vaccine nanoplatform},
  journal = {Journal of Microbiology},
  year = {2026},
  volume = {64},
  number = {5},
  pages = {e2511020},
  doi = {10.71150/jm.2511020}
}
Kostenlos starten →